AzTrials
AzTrials

Occlusal CariesNCT06803537

Three-Year Clinical Performance of Fiber-reinforced Versus Indirect Resin Composite Posterior Restorations

A study testing Fiber-reinforced composite, indirect lab composite and Conventional resin composite in people with Occlusal Caries and Proximal Caries, run by Mansoura University at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study aimed to perform a comparison between the clinical performance of short fiber-reinforced composite and indirect lab composite restorations in posterior dentition. Read more about this study

Who is it for?
Ages 20 to 35 years
Conditions the study is for
Occlusal Caries, Proximal Caries
What is being tested?
Fiber-reinforced composite, indirect lab composite and Conventional resin composite
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteEgypt
Study dates
1 Jan 2022to Jul 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients aged 20-35 year from both genders.
  • Good oral hygiene: patients with low and moderate caries risk (according to Caries management by caries risk assessment CAMBRA sheets) were enrolled in this study.
  • The visual examination should reveal the presence of a minimum of three primary occlusal or proximal caries (Black Class I and II) with a severity score of 4 or 5 according to the International Caries Detection and Assessment System (ICDAS).
  • The carious teeth must exhibit vitality and do not display periapical radiolucency as evaluated by periapical radiography.
  • The selected teeth must be under stable occlusion.

Who cannot join

  • Uncontrolled systemic disease
  • Extremely poor oral hygiene
  • Chronic periodontitis
  • Heavy bruxism
  • Cavities with a buccolingual width exceeding two-thirds of the intercuspal distance or requiring cusp covering.
  • Patients undergoing orthodontic procedures.
  • Patients unable to attend the scheduled recall appointments.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Mansoura university

    Al Mansurah, Dakahlia Governorate, 35516

Other trials in Egypt

About this study

This study aimed to perform a comparison between the clinical performance of short fiber-reinforced composite and indirect lab composite restorations in posterior dentition.

Being tested
Fiber-reinforced composite, indirect lab composite, Conventional resin composite
Keywords
fiber-reinforced composite, indirect lab composite, posterior restorations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fiber-reinforced compositeOther

    short fiber-reinforced composite used as base covered by conventional composite

  • indirect lab compositeOther

    indirect lab processed resin composite inlay restorations

  • Conventional resin compositeOther

    conventional microhybrid resin composite posterior restorations

Study groups in NCT06803537
Study groupRoleWhat they receive
Fiber-reinforced compositeActive comparatorNot described
Receives: Other: indirect lab composite; Other: Conventional resin composite
Indirect lab compositeActive comparatorNot described
Receives: Other: Fiber-reinforced composite; Other: Conventional resin composite
Conventional microhybrid resin compositeActive comparatorNot described
Receives: Other: Fiber-reinforced composite; Other: indirect lab composite

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. FDI criteria for evaluation

    Measured: Three years follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2025
  2. Study start1 Jan 2022
  3. Primary completionJul 2025 (estimated)
  4. Study completionJul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06803537
Sponsor's protocol ID
A02071221
Status last verified
Jan 2025
First submitted
27 Jan 2025
Last updated
11 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Salama RM, Hamama HH, Mahmoud SH. Clinical performance of short fiber-reinforced and indirect resin composites in class I and class II restorations: A three-year randomized clinical trial. Clin Oral Investig. 2025 Nov 21;29(12):580. doi: 10.1007/s00784-025-06593-x.

    PubMed 41269396

Questions about this trial

What is this clinical trial studying?

A study testing Fiber-reinforced composite, indirect lab composite and Conventional resin composite in people with Occlusal Caries and Proximal Caries, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 11 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

FDI criteria for evaluation (time frame: Three years follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06803537, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in